ADULT GROWTH HORMONE DEFICIENCY
Clinical trials for ADULT GROWTH HORMONE DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new ADULT GROWTH HORMONE DEFICIENCY trials appear
Sign up with your email to follow new studies for ADULT GROWTH HORMONE DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug sogroya tracked for Long-Term safety in growth hormone deficiency patients
Disease control OngoingThis study follows 200 adults in Japan with severe growth hormone deficiency who are taking Sogroya as part of their normal care. Researchers will monitor side effects and changes in body composition over 2 to 5 years. Participants will also complete quality-of-life questionnaire…
Matched conditions: ADULT GROWTH HORMONE DEFICIENCY
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Researchers track Sogroya's Long-Term safety in adults with growth hormone deficiency
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 400 adults with growth hormone deficiency who are already taking Sogroya as part of their normal care. Researchers will collect information on side effects and effectiveness over 5 to 10 years. Participants will also fill out short questionnaires about their we…
Matched conditions: ADULT GROWTH HORMONE DEFICIENCY
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 04, 2026 16:30 UTC